Showing 5531-5540 of 8624 results for "".
- Patient Enrollment Complete in Phase 3 Acne Trials for Minocycline Foam FMX101https://practicaldermatology.com/news/patient-enrollment-complete-in-phase-3-acne-trials-for-minocycline-foam-fmx101/2458357/Patient enrollment is now complete for two Phase 3 clinical trials evaluating the efficacy and safety of FMX101, a topical 4 percent minocycline foam for the treatment of moderate-to-severe acne, according to Foamix Pharmaceuticals Ltd. Foamix is con
- New Combo Therapy Beats Out Gold Standard Treatment For AKshttps://practicaldermatology.com/news/new-combo-therapy-beats-out-gold-standard-treatment-for-aks/2458360/Combining a cream formulation of 5-fluorouracil with a synthetic form of vitamin D called calcipotriol may trigger a robust immune response against actinic keratosis, according to research out of rom Washington University School of Medicine in St. Louis and Harvard Medical School in Boston.
- Consumer Reports IDs Teaching Hospitals That Expose Patients to Central Line Infectionshttps://practicaldermatology.com/news/consumer-reports-ids-teaching-hospitals-that-expose-patients-to-central-line-infections/2458366/Too many teaching hospitals are still exposing patients to dangerous bacteria via central line infections, according to Consumer Reports. The new report identifies
- New Day Cream, Gel Oil from Ceravehttps://practicaldermatology.com/news/new-day-cream-gel-oil-from-cerave/2458371/Cerave is expanding their Renewing product line. A new Cerave Skin Renewing Day Cream with Broad Spectrum SPF 30 sunscreen and Skin Renewing Gel Oil now join existing products in this line including Renewing Cream Serum and Renewing Night Cream.
- Derms Commonly Misdiagnose Fungal Skin Infectionshttps://practicaldermatology.com/news/fungal-skin-infections-commonly-misdiagnosed/2458372/Fungal skin infections may be commonly misdiagnosed, according to a survey in the Journal of the American Academy of Dermatology. George Washington University (GW) dermatologist Adam Friedman, MD and colleag
- US Attorney Announces Charges Against Two Executives Tied to Philidor Pharmacy Schemehttps://practicaldermatology.com/news/us-attorney-announces-charges-against-two-executives-tied-to-philidor-pharmacy-scheme/2458373/The US Attorney’s Office, Southern District of New York has charged two executives in connection with the Philidor Pharmacy scheme that instigated a stock value plunge at Valeant when it was revealed last year. The US Attorney’s office will hold a press conference today to
- Precision Medicine in Action: Clinical Features May Help ID High Risk Melanoma Patientshttps://practicaldermatology.com/news/precision-medicine-in-action-clinical-featires-may-help-id-high-risk-melanoma-patients/2458379/Zeroing in on an individual’s risk factors for melanoma can help identify high-risk patients who may benefit from increased surveillance, new research suggests. Caroline G. Watts, M.P.H., of the University of Sydney, Australia, and coauthors examined clinical features associated wit
- NPF Offers Open Enrollment Insurance Advice Via New Patient Navigation Centerhttps://practicaldermatology.com/news/national-psoriasis-foundation-offers-open-enrollment-insurance-advice-via-new-patient-navigation-center/2458380/The National Psoriasis Foundation (NPF) Patient Navigation Center aims to help patients l
- Most Indoor Tanning Salons in Texas Do Comply with Tanning Bans for Minorshttps://practicaldermatology.com/news/most-indoor-tanning-salons-in-texas-do-comply-with-tanning-bans-for-minors/2458378/Most indoor tanning salons comply with Texas’ tanning ban for those under 18, new research suggests. When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor ta
- FDA Clears Syneron Candela's Profound SubQ to Improve Cellulitehttps://practicaldermatology.com/news/fda-clears-syneron-candelas-profound-subq-to-improve-cellulite/2458381/Syneron Candela received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as supported by long term data (6 months). A recent multi-center clinical study of Profound sh